Ireland
--:--IST
Recruiting Not applicable

Addtional Effect of Hyperbaric Oxygen to Programmed Physical Activity on Musckoloskeletal Pain in Breast Cancer Elderly

NCT07662629 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2026-05-07
Last updated
2026-06-23

Condition(s) studied

Breast Cancer

Investigational drug(s) / intervention(s)

hyperbaric therapy and exerciseexercise

hyperbaric therapy and exercise: Twenty elder survivors from breast cancer with musckolskeletal pains resultes from aromatase inhibitor intake received phsyical activity program (aerobci training on traedmill and strengtheining protcol thrice weekly fro 2 month) and additinally received one-hour hyperbaric therapy session , five times weekly for 2 month.

exercise: Twenty elder survivors from breast cancer with musckolskeletal pains resultes from aromatase inhibitor intake received phsyical activity program (aerobci training on traedmill and strengtheining protcol thrice weekly for 2 month).

Study summary

patienst who survived from breast cancer are prescribed long administraion of aromatase inhbitors.. these inhibitors usually induce musckloskeletal pains. Programmed phsyical activity are reommended to improve these pains but effects of HYperbaric oxygen on these pain was not investigated

Eligibility

Sex
FEMALE
Min age
65 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * braest cancer survivors * patients receiving aramatase inhibitor drugs * patients with musckolskeletal pains Exclusion Criteria: * cardiac patients * respiratory patients * renal patients

Primary outcome measure(s)

  • visual analogue scale — it will be measured after 2 months
    it self asessmant of pain level

Trial sites (1)

FacilityCityRegionStatus
Cairo University Dokki Giza Governorate Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07662629 on ClinicalTrials.gov ↗ ← All trials in Egypt